Literature DB >> 22415584

Boy with autosomal recessive polycystic kidney and autosomal dominant polycystic liver disease.

Andrea Zingg-Schenk1, Jürg Caduff, Silvia Azzarello-Burri, Carsten Bergmann, Joost P H Drenth, Thomas J Neuhaus.   

Abstract

BACKGROUND: Autosomal recessive polycystic kidney disease (ARPKD) shows a great phenotypic variability between patients, ranging from perinatal demise to mildly affected adults. Autosomal dominant polycystic liver disease (PCLD) does not manifest in childhood. CASE-DIAGNOSIS/TREATMENT: A boy was reported with the co-occurrence of ARPKD and PCLD. He presented at the age of 16 days with pyelonephritis and urosepsis. Subsequent investigations showed enlarged kidneys and hyperechogenic renal medulla and liver parenchyma. Genetic analysis revealed compound heterozygous mutations in the PKHD1 gene (p.Arg496X and p.Ser1862Leu). After his mother was diagnosed with PCLD, the finding of a liver cyst on ultrasound prompted analysis of the PRKCSH gene, revealing a missense mutation (p.Arg139His). At the most recent follow-up at 13 years of age, the patient's course and clinical examination was uneventful with normal renal and liver function without evidence of portal hypertension.
CONCLUSIONS: The patient with ARPKD and PCLD has so far demonstrated a benign clinical outcome, consistent with the great phenotypic variability of ARPKD and, apart from the liver cyst, asymptomatic manifestation of PCLD in childhood. However, close long-term follow-up is mandatory.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22415584     DOI: 10.1007/s00467-012-2137-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  12 in total

1.  Mutations in SEC63 cause autosomal dominant polycystic liver disease.

Authors:  Sonia Davila; Laszlo Furu; Ali G Gharavi; Xin Tian; Tamehito Onoe; Qi Qian; Airong Li; Yiqiang Cai; Patrick S Kamath; Bernard F King; Pablo J Azurmendi; Pia Tahvanainen; Helena Kääriäinen; Krister Höckerstedt; Olivier Devuyst; Yves Pirson; Rodolfo S Martin; Richard P Lifton; Esa Tahvanainen; Vicente E Torres; Stefan Somlo
Journal:  Nat Genet       Date:  2004-05-09       Impact factor: 38.330

2.  Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease.

Authors:  Esmé Waanders; René H M te Morsche; Rob A de Man; Jan B M J Jansen; Joost P H Drenth
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

Review 3.  Polycystic liver and kidney diseases.

Authors:  Esa Tahvanainen; Pia Tahvanainen; Helena Kääriäinen; Krister Höckerstedt
Journal:  Ann Med       Date:  2005       Impact factor: 4.709

4.  Abdominal sonographic study of autosomal dominant polycystic kidney disease.

Authors:  C Nicolau; R Torra; L Bianchi; R Vilana; R Gilabert; A Darnell; C Brú
Journal:  J Clin Ultrasound       Date:  2000 Jul-Aug       Impact factor: 0.910

5.  Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD).

Authors:  Carsten Bergmann; Jan Senderek; Ellen Windelen; Fabian Küpper; Iris Middeldorf; Frank Schneider; Christian Dornia; Sabine Rudnik-Schöneborn; Martin Konrad; Claus P Schmitt; Tomas Seeman; Thomas J Neuhaus; Udo Vester; Jutta Kirfel; Reinhard Büttner; Klaus Zerres
Journal:  Kidney Int       Date:  2005-03       Impact factor: 10.612

Review 6.  Polycystic liver disease is a disorder of cotranslational protein processing.

Authors:  Joost P H Drenth; Jose A Martina; Rolf van de Kerkhof; Juan S Bonifacino; Jan B M J Jansen
Journal:  Trends Mol Med       Date:  2005-01       Impact factor: 11.951

7.  Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease.

Authors:  Joost P H Drenth; Rene H M te Morsche; Renate Smink; Juan S Bonifacino; Jan B M J Jansen
Journal:  Nat Genet       Date:  2003-02-10       Impact factor: 38.330

Review 8.  Fibropolycystic liver disease in children.

Authors:  Myka Call Veigel; Julia Prescott-Focht; Michael G Rodriguez; Reza Zinati; Lei Shao; Charlotte A W Moore; Lisa H Lowe
Journal:  Pediatr Radiol       Date:  2008-12-16

9.  Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63.

Authors:  E Waanders; H Venselaar; R H M te Morsche; D B de Koning; P S Kamath; V E Torres; S Somlo; J P H Drenth
Journal:  Clin Genet       Date:  2010-01-20       Impact factor: 4.438

10.  Clinical profile of autosomal dominant polycystic liver disease.

Authors:  Qi Qian; Airong Li; Bernard F King; Patrick S Kamath; Donna J Lager; John Huston; Clarence Shub; Sonia Davila; Stefan Somlo; Vicente E Torres
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

View more
  1 in total

Review 1.  Clinical manifestations of autosomal recessive polycystic kidney disease (ARPKD): kidney-related and non-kidney-related phenotypes.

Authors:  Rainer Büscher; Anja K Büscher; Stefanie Weber; Julia Mohr; Bianca Hegen; Udo Vester; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2013-10-10       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.